Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Facon

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Leukemia|March 5, 2004
Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factorI Vande Broek, K Asosingh, V Allegaert, et al.
Bone Marrow Transplantation|July 1, 1994
Cytomegalovirus expression in minor salivary glands and chronic graft-versus-host diseaseI Quiquandon, A Janin, M P Noel-Walter, et al.
The New England Journal of Medicine|October 31, 1991
Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow TransplantationG Gahrton, S Tura, P Ljungman, et al.
La Revue De Medecine Interne|January 1, 1993
[Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis]L Maulin, E Hachulla, T Facon, et al.
British Journal of Haematology|August 1, 1993
Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patientsT Facon, J L Lai, E Nataf, et al.
Journal of Clinical Pathology|June 1, 1995
CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significanceM Zandecki, T Facon, F Bernardi, et al.
American Journal of Hematology|February 1, 1993
Early paternity and relapse after bone marrow transplantationT Facon, J P Jouet, J L Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabineJ L Harousseau, J Reiffers, P Hurteloup, et al.
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
Leukemia|February 20, 1999
Isolated neurological relapse following stem cell transplantation in plasma cell leukemia: a report of two casesX Leleu, J P Jouet, I Plantier, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Leukemia|March 5, 2004
Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factorI Vande Broek, K Asosingh, V Allegaert, et al.
Bone Marrow Transplantation|July 1, 1994
Cytomegalovirus expression in minor salivary glands and chronic graft-versus-host diseaseI Quiquandon, A Janin, M P Noel-Walter, et al.
The New England Journal of Medicine|October 31, 1991
Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow TransplantationG Gahrton, S Tura, P Ljungman, et al.
La Revue De Medecine Interne|January 1, 1993
[Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis]L Maulin, E Hachulla, T Facon, et al.
British Journal of Haematology|August 1, 1993
Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patientsT Facon, J L Lai, E Nataf, et al.
Journal of Clinical Pathology|June 1, 1995
CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significanceM Zandecki, T Facon, F Bernardi, et al.
American Journal of Hematology|February 1, 1993
Early paternity and relapse after bone marrow transplantationT Facon, J P Jouet, J L Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabineJ L Harousseau, J Reiffers, P Hurteloup, et al.
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
Leukemia|February 20, 1999
Isolated neurological relapse following stem cell transplantation in plasma cell leukemia: a report of two casesX Leleu, J P Jouet, I Plantier, et al.
Pageof 13